Development of Methods for Effective Treatment and Improvement of Common Somatic Diseases in Children
Recruiting
Early Phase 1
Interventional Study
Respiratory Diseases
Congenital Heart Defects
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 3 Days – 15
- Sex
- Any
- Trial phase
- Early Phase 1
- Study type
- Interventional
- Purpose
- Supportive Care
- Participants needed
- 110 (estimated)
- Sponsor
- Tashkent State Medical University (Tashkent Pediatric Medical Institute), Uzbekistan · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The goal of the clinical study is to clarify the course of common congenital, infectious, and non-infectious diseases in children living in Uzbekistan, and to develop methods for their treatment and rehabilitation.
The main questions it aims to answer:
* Analysis of common congenital diseases among children;
* Analysis of commonly diagnosed bronchopulmonary and cardiovascular diseases among chil…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* children from birth to 15 years;
* children permanently residing in the territory where the clinical examination is carried out;
* children included in the group of "frequently ill children";
* patients without severe chronic diseases.
Exclusion Criteria:
* Teenagers over 15…
Contacts